These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 10109180)

  • 1. Bolar agrees to guilty plea in generic drug probe.
    Wagner M
    Mod Healthc; 1991 Mar; 21(9):17. PubMed ID: 10109180
    [No Abstract]   [Full Text] [Related]  

  • 2. FDA takes action against firms in scandal over generic products.
    Pollner F
    Med World News; 1989 Sep; 30(17):14-5. PubMed ID: 10294736
    [No Abstract]   [Full Text] [Related]  

  • 3. Indian generics manufacturer Ranbaxy agrees to pay $500m to settle US fraud and drug safety charges.
    Kay M
    BMJ; 2013 May; 346():f3536. PubMed ID: 23723460
    [No Abstract]   [Full Text] [Related]  

  • 4. Dismissal of investor fraud claim over HIV drug reversed.
    AIDS Policy Law; 2008 Nov; 23(12):8. PubMed ID: 19145698
    [No Abstract]   [Full Text] [Related]  

  • 5. Lawsuits anticipated on generic biologicals front.
    Fox JL
    Nat Biotechnol; 2003 Jul; 21(7):721-2. PubMed ID: 12833078
    [No Abstract]   [Full Text] [Related]  

  • 6. Generics still a favorite Rx for savings.
    Wagner M
    Mod Healthc; 1990 May; 20(21):26-8, 30, 32-3. PubMed ID: 10104890
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prescription drug advertising--should states regulate what is false and misleading?
    Shaeffer J
    Food Drug Law J; 2003; 58(4):629-48. PubMed ID: 15027454
    [No Abstract]   [Full Text] [Related]  

  • 8. Groups adapt to generic drug probe with buying strategies.
    Perry PA
    Hosp Mater Manage; 1989 Oct; 14(10):1, 14-5. PubMed ID: 10324694
    [No Abstract]   [Full Text] [Related]  

  • 9. Major events during the generic drug investigations.
    Am Pharm; 1990 Jul; NS30(7):38-9. PubMed ID: 2363392
    [No Abstract]   [Full Text] [Related]  

  • 10. Perspectives. FDA scandal: white hats, black hats, gray areas.
    Wiener JO
    Faulkner Grays Med Health; 1989 Dec; 43(48):suppl 6 p.. PubMed ID: 10296081
    [No Abstract]   [Full Text] [Related]  

  • 11. Generic drug purchasing.
    Mehl B
    Hosp Pharm; 1988 Feb; 23(2):162-4 contd. PubMed ID: 10286432
    [No Abstract]   [Full Text] [Related]  

  • 12. What's in a name? Generic vs brand name drugs.
    Levin AA
    Health PAC Bull; 1986 Jun; 16(5):37, 39. PubMed ID: 10276741
    [No Abstract]   [Full Text] [Related]  

  • 13. Drug probe expected to have modest impact.
    Tokarski C
    Mod Healthc; 1989 Sep; 19(35):4. PubMed ID: 10294523
    [No Abstract]   [Full Text] [Related]  

  • 14. Deterring the importation of counterfeit pharmaceutical products.
    Stearn DW
    Food Drug Law J; 2004; 59(4):537-61. PubMed ID: 15875351
    [No Abstract]   [Full Text] [Related]  

  • 15. Generic drug scandals raise questions about safety. FDA reorganizes to increase surveillance, prevent fraud.
    Martin S
    Am Pharm; 1989 Oct; NS29(10):23-4. PubMed ID: 2816714
    [No Abstract]   [Full Text] [Related]  

  • 16. Current issues in the pioneer versus generic drug wars.
    Safir PO
    Food Drug Law J; 1995; 50(2):335-9. PubMed ID: 10343002
    [No Abstract]   [Full Text] [Related]  

  • 17. Upjohn pharmacist reimbursement programs halted by FDA.
    Am J Hosp Pharm; 1993 Feb; 50(2):200, 205. PubMed ID: 8480773
    [No Abstract]   [Full Text] [Related]  

  • 18. Remarks by the Commissioner of Food and Drugs.
    Kessler DA
    Food Drug Law J; 1995; 50(2):327-34. PubMed ID: 10343001
    [No Abstract]   [Full Text] [Related]  

  • 19. DPS--the PMA perspective.
    Beary JF; Cleveland CB
    Am Pharm; 1992 May; NS32(5):6, 8. PubMed ID: 1590210
    [No Abstract]   [Full Text] [Related]  

  • 20. The brave new world of healthcare e-commerce.
    Hirsch R
    J Cardiovasc Manag; 1999; 10(3):13-4. PubMed ID: 10557912
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.